Updated: Feb 5, 2019
Brussels - 27 October 2014 – On 3 December 2014, leaders and experts from the whole medical devices and pharmaceutical packaging supply chain will meet in Brussels for the second workshop of MedPharmPlast Europe. Following up on the success of MedPharmPlast Europe last information event in June this year, the upcoming workshop focuses on European legislation and its impact on the medical devices and pharmaceutical packaging industries.
High-level speakers from these industry sectors will give an overview of the regulatory challenges they are facing including potential bans on key substances used in the production. Among others, the presentations will address the latest developments in the European legislation including the much discussed Amendment 355, new insights into substances like DEHP or Bisphenol A as well as the consequences of the Unique Device Identification for the supply chain. Next to the presentations, there is also time scheduled for panel discussions and network sessions. “For everyone involved in these industry sectors it is essential to stay updated on the latest developments in EU regulations,” outlines Christian Meusinger, President of MedPharmPlast Europe. “This aspect makes our event vitally important for participants from all sectors of the medical devices and pharmaceutical packaging industry”.
The MedPharmPlast workshop is open to everyone involved or interested in the medical devices and pharmaceutical packaging supply chain. If you would like to register for the event or receive more detailed information on it, please contact email@example.com or visit the website www.medpharmplasteurope.org